NASDAQ:ESTA Establishment Labs (ESTA) Stock Price, News & Analysis $63.85 -1.44 (-2.21%) Closing price 10/7/2026 04:00 PM EasternExtended Trading$63.97 +0.12 (+0.19%) As of 04:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Establishment Labs Stock (NASDAQ:ESTA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Establishment Labs alerts:Sign Up Key Stats Today's Range$63.68▼$65.9750-Day Range$63.04▼$94.6152-Week Range$38.38▼$97.59Volume438,394 shsAverage Volume329,184 shsMarket Capitalization$1.90 billionP/E RatioN/ADividend YieldN/APrice Target$100.25Consensus RatingModerate Buy Company Overview Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a medical technology company focused on women’s health and breast aesthetics. The company develops, manufactures and markets medical devices intended for breast augmentation, reconstruction and related procedures. Its principal product portfolio includes Motiva breast implants, a line of silicone-gel implants designed for aesthetic and reconstructive applications, as well as tissue expanders and other products used in breast surgery. Establishment Labs also offers Mia Femtech, a technology and procedure platform designed to support a less invasive approach to breast augmentation. Founded in 2004, Establishment Labs is headquartered in Costa Rica and serves healthcare providers and patients in international markets. Its products have been distributed globally, with the company historically maintaining a presence across Europe, Latin America, Asia and other regions. The company was founded by Juan José Chacón-Quesada, who serves as its chief executive officer.AI Generated. May Contain Errors. Read More Establishment Labs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks65th Percentile Overall ScoreESTA MarketRank™: Establishment Labs scored higher than 65% of companies evaluated by MarketBeat, and ranked 263rd out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingEstablishment Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 8 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialEstablishment Labs has a consensus price target of $100.25, representing about 57.0% upside from its current price of $63.85.Amount of Analyst CoverageEstablishment Labs has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Establishment Labs' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Establishment Labs are expected to grow in the coming year, from ($1.15) to $0.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -48.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -48.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 78.83. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Establishment Labs' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.35% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 12.76, which indicates bearish sentiment.Change versus previous monthShort interest in Establishment Labs has recently decreased by 0.23%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. News and Social Media3.8 / 5News Sentiment1.04 News SentimentEstablishment Labs has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Establishment Labs this week, compared to 3 articles on an average week.Search Interest2 people have searched for ESTA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have not sold or bought any company stock.Percentage Held by Insiders9.99% of the stock of Establishment Labs is held by insiders.Percentage Held by Institutions72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Establishment Labs' insider trading history. Receive ESTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ESTA Stock News HeadlinesEstablishment Labs Holdings (ESTA) Wins Expanded FDA Clearance, Is The Stock Still A Bargain?October 7 at 3:43 AM | finance.yahoo.comEstablishment Labs Holdings Inc. Receives Fda Approval for Expanded Range of Motiva Smoothsilk Round and Motiva Smoothsilk Ergonomix Breast ImplantsOctober 6 at 12:34 PM | marketscreener.comMThey're not telling you how bad this could getValuations have reached levels seen only a handful of times in the past century, while debt concerns and tariff-driven supply chain shocks continue to build beneath market headlines. Parkview Capital's new Market Crash Survival Guide breaks down what's happening under the surface and how investors are positioning their retirement savings in response. | Parkview Capital Group (Ad)Establishment Labs Says US FDA Approves Additional Sizes of Motiva ImplantsOctober 5 at 3:35 PM | marketscreener.comMEstablishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®October 5 at 9:20 AM | finance.yahoo.comEstablishment Labs Holdings (ESTA) Gets a Buy from TD CowenSeptember 27, 2026 | theglobeandmail.comIs Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity?September 23, 2026 | finance.yahoo.comEstablishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic ImplantsSeptember 21, 2026 | finance.yahoo.comSee More Headlines ESTA Stock Analysis - Frequently Asked Questions How have ESTA shares performed this year? Establishment Labs' stock was trading at $72.88 at the start of the year. Since then, ESTA shares have decreased by 12.4% and is now trading at $63.85. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc. (NASDAQ:ESTA) issued its quarterly earnings data on Thursday, August, 6th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.05. The company's quarterly revenue was up 31.7% compared to the same quarter last year. Read the conference call transcript. When did Establishment Labs IPO? Establishment Labs (ESTA) raised $59 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,715,277 shares at $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager. How do I buy shares of Establishment Labs? Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include PayPal (PYPL), NVIDIA (NVDA), Walt Disney (DIS), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD) and Intel (INTC). Company Calendar Last Earnings8/06/2026Today10/08/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 As of 2 days ago, ESTA's financial health entered the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:ESTA CIK1688757 Webwww.establishmentlabs.com Phone(062) 434-2400FaxN/AEmployees1,004Year Founded2004Price Target and Rating Average Price Target for Establishment Labs$100.25 High Price Target$117.00 Low Price Target$90.00 Potential Upside/Downside+57.0%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)($1.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$51.06 million Net Margins-15.82% Pretax Margin-19.31% Return on Equity-196.69% Return on Assets-10.73% Debt Debt-to-Equity Ratio12.11 Current Ratio3.84 Quick Ratio2.52 Sales & Book Value Annual Sales$211.08 million Price / Sales9.01 Cash FlowN/A Price / Cash FlowN/A Book Value$0.81 per share Price / Book78.83Miscellaneous Outstanding Shares29,800,000Free Float26,825,000Market Cap$1.90 billion OptionableOptionable Beta1.06 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:ESTA) was last updated on 10/8/2026 by MarketBeat.com Staff. From Our PartnersWhat Could Change After November 3rd?Democrats are favored to take the House on November 3rd, needing just five seats to flip the chamber. The last...USA Capital Gold | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredChina ATTACK on American Dollar set for 11/12/2026A former Wall Street Journal personal finance expert warns China may be setting the stage for a major move aga...International Living | SponsoredA dividend every week of the yearMost dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering ...Market Savvy | Sponsored“Whoever wins AI, wins”Jason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
